Pascal Bamford - 01 Jun 2025 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Reporting relationship: Chief Clinical Officer
Issuer ticker: AKYA
Reported as of: 01 Jun 2025
Net transaction value: -$838
SEC form: 4
Accepted by SEC: 02 Jun 2025, 17:52:39 UTC
Prior SEC filing: 04 Mar 2025
Next SEC filing: 10 Jul 2025
Source filing: View source filing
Reporting owner signature: /s/ Pascal Bamford by Brian McKelligon, Attorney-in-Fact

Key filing fact

Pascal Bamford filed Form 4 for Akoya Biosciences, Inc. (AKYA) on 02 Jun 2025.

Key facts

This page summarizes Pascal Bamford's Form 4 filing for Akoya Biosciences, Inc. (AKYA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Jun 2025, 17:52.

Change

Previous filing in this sequence was filed on 04 Mar 2025.
Current net transaction value: -$838.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002035474 Primary reporting owner

BAMFORD PASCAL

Relationship: Chief Clinical Officer
Address: C/O AKOYA BIOSCIENCES, INC., 100 CAMPUS DRIVE, 6TH FLOOR, MARLBOROUGH
Signature: /s/ Pascal Bamford by Brian McKelligon, Attorney-in-Fact
Signature date: 02 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AKYA transaction

Common Stock

Tax liability

Transaction value: $838
Shares: -670
Change %: -0.32%
Price: $1.25
Shares after: 205,738
Date: 01 Jun 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld to cover taxes on a restricted stock unit award previously granted on May 18, 2023, which vests in four (4) annual equal installments beginning on June 1, 2024 and annually thereafter until fully vested.